Features Screener Stocks Charts
Sign In Sign Up

Sun Pharmaceutical Industries Ltd. Income Statement

NSE:SUNPHARMA | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year SUNPHARMA income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 498.51B 525.78B
Cost of Revenue -106.63B -107.47B
Gross Profit 391.88B 418.31B
Sales, General & Admin -248.11B -267.45B
Operating Income 118.21B 125.11B
Profit Before Tax 110.88B 137.52B
Net Income 96.10B 109.29B
Diluted Shares 2.40B 2.40B
Diluted EPS 39.90 45.60

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025